HOPE4MCI trial: First trial targeting reduction of hippocampal overactivity to treat mild cognitive impairment due to Alzheimer’s disease with AGB101
Autor: | Chris J. Edgar, Michela Gallagher, Russell Barton, Sharon Rosenzweig-Lipson, Richard C. Mohs, Paul Maruff |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty Epidemiology business.industry Health Policy Disease Hippocampal formation Reduction (complexity) Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Internal medicine medicine Neurology (clinical) Geriatrics and Gerontology Cognitive impairment business |
Zdroj: | Alzheimer's & Dementia. 16 |
ISSN: | 1552-5279 1552-5260 |
Databáze: | OpenAIRE |
Externí odkaz: |